Bloomberg Law
Oct. 31, 2018, 10:33 AM

What’s Your Health Data Worth? Startups Want to Help You Sell It

Sara Merken
Sara Merken
Dana A. Elfin
Dana A. Elfin

Startups Embleema,, and Nebula Genomics are banking that consumers, already sold on the idea of handing over their genetic data to DNA testing companies, will want to control how that data is used and make some money at the same time.

The three are among the companies that want to help you take control of your medical data and sell it too. They plan to provide individuals’ genomic and other health data to researchers and pharmaceutical companies.

The worldwide market for patient medical data is potentially huge, with estimates running as high as $67 billion. Embleema,, and Nebula ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.